SEC Filings

SEC Filings

Filing date	Description	Form	View
Jan 12, 2018	A statement of beneficial ownership of common stock by certain persons	SC 13G	View HTML 0001193125-18-010102.pdf 0001193125-18-010102.rtf 0001193125-18-010102.xls
Jan 04, 2018	Statement of changes in beneficial ownership of securities	4	View HTML 0001214659-18-000184.pdf 0001214659-18-000184.rtf 0001214659-18-000184.xls
Jan 04, 2018	Statement of changes in beneficial ownership of securities	4	View HTML 0001214659-18-000185.pdf 0001214659-18-000185.rtf 0001214659-18-000185.xls
Jan 04, 2018	Statement of changes in beneficial ownership of securities	4	View HTML 0001214659-18-000186.pdf 0001214659-18-000186.rtf 0001214659-18-000186.xls
Jan 04, 2018	Statement of changes in beneficial ownership of securities	4	View HTML 0001214659-18-000187.pdf 0001214659-18-000187.rtf 0001214659-18-000187.xls
Jan 04, 2018	Statement of changes in beneficial ownership of securities	4	View HTML 0001214659-18-000188.pdf 0001214659-18-000188.rtf 0001214659-18-000188.xls
Jan 04, 2018	Statement of changes in beneficial ownership of securities	4	View HTML 0001214659-18-000189.pdf 0001214659-18-000189.rtf 0001214659-18-000189.xls
Jan 04, 2018	Statement of changes in beneficial ownership of securities	4	View HTML 0001214659-18-000190.pdf 0001214659-18-000190.rtf 0001214659-18-000190.xls
Jan 04, 2018	Statement of changes in beneficial ownership of securities	4	View HTML 0001214659-18-000191.pdf 0001214659-18-000191.rtf 0001214659-18-000191.xls
Jan 04, 2018	Statement of changes in beneficial ownership of securities	4	View HTML 0001214659-18-000192.pdf 0001214659-18-000192.rtf 0001214659-18-000192.xls

Data provided by Kaleidoscope.

For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE